Aventis To Face Whistleblower Claims Over Lovenox

Law360, New York (September 14, 2007, 12:00 AM EDT) -- A federal judge has allowed certain whistleblower claims to move forward in a case brought by two former Sanofi-Aventis Pharmaceuticals Inc. sales representatives who claim they were retaliated against after accusing the company of promoting off-label marketing for its popular anti-clotting drug Lovenox.

In a memorandum opinion and order issued Friday in the U.S. District Court for the Northern District of Illinois, Judge Matthew F. Kennelly granted in part and denied in part bids by Aventis and PharmaNetics, Inc. to dismiss the amended complaint of relators...
To view the full article, register now.